News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,128 Results
Type
Article (46385)
Company Profile (352)
Press Release (704373)
Multimedia
Podcasts (151)
Webinars (21)
Section
Business (208739)
Career Advice (2050)
Deals (36176)
Drug Delivery (148)
Drug Development (84613)
Employer Resources (175)
FDA (17087)
Job Trends (15250)
News (354693)
Policy (33507)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2733)
Academic (1)
Accelerated approval (54)
Adcomms (36)
Allergies (179)
Alliances (50947)
ALS (220)
Alzheimer's disease (1886)
Antibody-drug conjugate (ADC) (509)
Approvals (17441)
Artificial intelligence (716)
Autoimmune disease (329)
Automation (60)
Bankruptcy (367)
Best Places to Work (11853)
BIOSECURE Act (23)
Biosimilars (232)
Biotechnology (234)
Bladder cancer (207)
Brain cancer (82)
Breast cancer (809)
Cancer (6231)
Cardiovascular disease (519)
Career advice (1744)
Career pathing (43)
CAR-T (369)
CDC (61)
Celiac Disease (3)
Cell therapy (1025)
Cervical cancer (50)
Clinical research (73364)
Collaboration (2223)
Company closure (7)
Compensation (1455)
Complete response letters (96)
COVID-19 (2834)
CRISPR (119)
C-suite (1203)
Cystic fibrosis (164)
Data (8285)
Decentralized trials (3)
Denatured (38)
Depression (180)
Dermatology (94)
Diabetes (621)
Diagnostics (7094)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (351)
Drug pricing (218)
Drug shortages (34)
Duchenne muscular dystrophy (310)
Earnings (93162)
Editorial (73)
Employer branding (21)
Employer resources (154)
Events (123207)
Executive appointments (1126)
FDA (20959)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1826)
Gene editing (259)
Generative AI (61)
Gene therapy (835)
GLP-1 (1157)
Government (4879)
Grass and pollen (6)
Guidances (412)
Healthcare (19601)
HIV (88)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (323)
Immuno-oncology (106)
Indications (197)
Infectious disease (3192)
Inflammatory bowel disease (230)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (303)
Interviews (321)
IPO (16916)
IRA (52)
Job creations (3712)
Job search strategy (1443)
JPM (69)
Kidney cancer (21)
Labor market (104)
Layoffs (612)
Leadership (43)
Legal (8061)
Liver cancer (106)
Longevity (35)
Lung cancer (816)
Lymphoma (446)
Machine learning (63)
Management (59)
Manufacturing (1111)
MASH (215)
Medical device (14203)
Medtech (14337)
Mergers & acquisitions (20532)
Metabolic disorders (1644)
mRNA (239)
Multiple sclerosis (195)
NASH (19)
Neurodegenerative disease (469)
Neuropsychiatric disorders (114)
Neuroscience (3506)
Neurotech (1)
NextGen: Class of 2026 (6735)
Non-profit (4638)
Now hiring (79)
Obesity (777)
Opinion (311)
Ovarian cancer (233)
Pain (275)
Pancreatic cancer (321)
Parkinson's disease (390)
Partnered (34)
Patents (619)
Patient recruitment (718)
Peanut (64)
People (60828)
Pharmaceutical (74)
Pharmacy benefit managers (33)
Phase 1 (22916)
Phase 2 (32266)
Phase 3 (24043)
Pipeline (9204)
Policy (349)
Postmarket research (2728)
Preclinical (9790)
Press Release (69)
Prostate cancer (328)
Psychedelics (66)
Radiopharmaceuticals (353)
Rare diseases (1195)
Real estate (6081)
Recruiting (72)
Regulatory (26254)
Reports (57)
Research institute (2531)
Resumes & cover letters (356)
Rett syndrome (40)
RNA editing (26)
RSV (90)
Schizophrenia (185)
Series A (308)
Series B (226)
Service/supplier (12)
Sickle cell disease (121)
Special edition (31)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (3783)
State (2)
Stomach cancer (21)
Supply chain (131)
Tariffs (92)
The Weekly (110)
Vaccines (1163)
Venture capital (117)
Weight loss (516)
Women's health (132)
Worklife (21)
Date
Today (150)
Last 7 days (657)
Last 30 days (3551)
Last 365 days (31314)
2026 (14040)
2025 (31276)
2024 (36303)
2023 (41050)
2022 (52299)
2021 (56824)
2020 (55096)
2019 (47633)
2018 (35955)
2017 (33037)
2016 (32444)
2015 (38452)
2014 (32166)
2013 (27179)
2012 (29335)
2011 (30046)
2010 (28197)
Location
Africa (771)
Alabama (93)
Alaska (7)
Arizona (358)
Arkansas (14)
Asia (41212)
Australia (6835)
California (13749)
Canada (3854)
China (1454)
Colorado (589)
Connecticut (598)
Delaware (418)
Europe (91409)
Florida (2070)
Georgia (447)
Hawaii (3)
Idaho (63)
Illinois (1097)
India (95)
Indiana (617)
Iowa (24)
Japan (562)
Kansas (137)
Kentucky (51)
Louisiana (47)
Maine (76)
Maryland (1634)
Massachusetts (9937)
Michigan (371)
Minnesota (737)
Mississippi (6)
Missouri (157)
Montana (34)
Nebraska (29)
Nevada (145)
New Hampshire (89)
New Jersey (3602)
New Mexico (33)
New York (3624)
North Carolina (1800)
North Dakota (11)
Northern California (6896)
Ohio (409)
Oklahoma (24)
Oregon (42)
Pennsylvania (2752)
Puerto Rico (29)
Rhode Island (50)
South America (1137)
South Carolina (87)
South Dakota (2)
Southern California (5400)
Tennessee (218)
Texas (2198)
United States (48673)
Utah (407)
Vermont (1)
Virginia (328)
Washington D.C. (83)
Washington State (1096)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
751,128 Results for "chimeric therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics’ CDH17 Autologous CAR‑T Program
April 21, 2026
·
5 min read
Press Releases
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
April 15, 2026
·
7 min read
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
La Jolla Labs, Inc. Announces First Patient Treated with Custom Antisense Therapy GBFsen for familial ALS
April 30, 2026
·
1 min read
Press Releases
Osel Inc. and March of Dimes Announce Groundbreaking Phase 2b Trial of Microbiome-based Therapy Targeting Preterm Birth Prevention
May 13, 2026
·
7 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies
May 12, 2026
·
6 min read
Opinion
Gene therapy’s evidence problem—lessons from recent FDA decisions
Comprehending the spate of recent rejections in the cell and gene therapy space may require looking no further than early-stage clinical trials of candidates from REGENXBIO, Excision BioTherapeutics and Intellia Therapeutics.
May 4, 2026
·
6 min read
·
Jenna DiRito
Press Releases
A2 Biotherapeutics Presents Safety and Efficacy Data from the EVEREST-2 Clinical Study, Including Update on the First Complete Response to CAR T-Cell Therapy in a Patient with Non-Small Cell Lung Cancer
May 22, 2026
·
6 min read
Press Releases
Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.
February 10, 2026
·
2 min read
Gene therapy
4 spaces primed for the next wave of gene therapies
The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here,
BioSpace
reviews genetic medicines in development for the central nervous system, retinal, cardiac and neuromuscular diseases.
May 18, 2026
·
8 min read
·
Andrea Park
1 of 75,113
Next
